Advertisements


Intercept Reports Phase III Sub-Study Liver Biopsy Data

Intercept (ICPT) announces data from the POISE biopsy sub-study which showed that treatment with obeticholic acid leads to the reversal or stabilization of fibrosis/cirrhosis in patien.....»»

Category: worldSource: nytApr 16th, 2018

Intercept announces data from liver biopsy substudy of POISE Phase 3 trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 13th, 2018

How Intercept Pharma Shatters Expectations With Its Liver Fibrosis Treatment

Intercept Pharmaceuticals shares jumped on Tuesday after the firm announced results for its Phase 3 Regenerate study of obeticholic acid in patients with liver fibrosis due to nonalcoholic........»»

Category: blogSource: 247wallstFeb 19th, 2019

Amgen/Allergan"s Rituxan Biosimilar Meets Goal in Phase III

Amgen (AMGN) along with partner Allergan reports upbeat top-line data from a phase I/III study on ABP 798.....»»

Category: dealsSource: nytJan 25th, 2019

Vertex"s (VRTX) 3rd Study on Pain Drug Meets Primary Endpoint

Vertex (VRTX) reports positive phase II data of its pipeline candidate VX-150 in patients with pain caused by small fiber neuropathy. .....»»

Category: personnelSource: nytDec 19th, 2018

Agios reports updated data from Phase 1 ivosidenib, enasidenib study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 3rd, 2018

AbbVie reports "positive" data from Phase 2b/3 study of upadacitinib

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 22nd, 2018

Theravance Biopharma reports data from TD-1473 Phase 1b study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 22nd, 2018

Anika Reports Top Line Data from CINGAL Study, Shares Slump

Anika Therapeutics' (ANIK) shares declined 37%, after the company reported disappointing data from its phase III Cingal 16-02 study in treating patients with osteoarthritis (OA) in the knee. Sha.....»»

Category: smallbizSource: nytJun 21st, 2018

Bluebird Bio reports interim data from Phase 1 HGB-206 study of LentiGlobin

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 15th, 2018

Epizyme reports updated interim data from Phase 2 study of tazemetostat

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 15th, 2018

Nightstar Therapeutics Reports First Quarter 2018 Financial Results and Acceleration of Preliminary NSR-RPGR Readout to Third Quarter 2018

Preliminary data from dose escalation study in the Phase 1/2 XIRIUS trial for X-Linked Retinitis Pigm.....»»

Category: earningsSource: benzingaJun 6th, 2018

Teva reports publication of Phase III HALO study data in JAMA

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 15th, 2018

Aptinyx Reports Fourth Quarter and Full Year 2018 Financial Results and Highlights Pipeline and Business Progress

Completed Phase 2 study of NYX-2925 in painful DPN -- did not meet primary endpoint, but NYX-2925 demonstrated robust analgesic activity in a large and mechanistically relevant patient sub-group Reported positive da.....»»

Category: earningsSource: benzingaMar 21st, 2019

Altimmune announces additional data from phase 2 NasoVAX study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 19th, 2019

Scholar Rock Reports Full Year 2018 Financial Results and Highlights Business Progress

Initiated and Progressed Phase 1 Clinical Trial of SRK-015 in Healthy Volunteers, Transitioning to a Clinical-Stage Company Presented Compelling Preclinical Data from the SRK-181 Cancer Immunotherapy Program at the Society for .....»»

Category: earningsSource: benzingaMar 18th, 2019

Bristol-Myers & Pfizer Release Phase IV Data on Eliquis

Bristol-Myers (BMY) and partner Pfizer ) announce results from the phase IV - AUGUSTUS study evaluating Eliquis (apixaban) versus vitamin K antagonists (V.....»»

Category: dealsSource: nytMar 18th, 2019

Vaccinex Reports Fourth Quarter 2018 Financial Results and Provides Corporate Update

Initial data from ongoing open label study of pepinemab (VX15/2503) in combination with avelumab in non-small cell lung cancer expected in 2Q 2019 Enroll.....»»

Category: earningsSource: benzingaMar 13th, 2019

Chiasma Reports Fourth Quarter and Year End 2018 Results

On track for top-line data from Phase 3 CHIASMA OPTIMA.....»»

Category: earningsSource: benzingaMar 8th, 2019

Concert Pharmaceuticals reports interim CTP-543 Phase 2 data in alopecia areata

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 1st, 2019

Recro Pharma publishes clinical data from Phase III study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 25th, 2019